| Abstrakt: |
A recent report from AGH University of Science and Technology highlights the connection between colorectal cancer (CRC) and the intestinal microbiota. The researchers focused on the role of vitamin K2 (VK2), a compound produced by gut bacteria, in inhibiting colorectal carcinogenesis. The study tested 86 bacterial strains and found that certain strains, such as Lactobacillus, Bifidobacterium, and Bacillus, were the largest producers of VK2. The research also demonstrated that VK2 had no harmful effects on tested cells and showed potential in inhibiting the secretion of pro-inflammatory cytokines. [Extracted from the article] |
